Architects of Regeneration
Since the 1980s, Geistlich Pharma has been a leader in the research and production of biomaterials for bone and cartilage regeneration. As a pioneer in regenerative medicine, Geistlich has contributed significantly to the development of less invasive surgical techniques that are now possible. Now patients suffer less pain and we understand how to leverage the body’s own healing processes for enduring results.
The collagen matrix Chondro-Gide® developed by Geistlich Pharma was launched 20 years ago. It exemplifies our innovative strength as a company. To celebrate this anniversary, we have profiled some of the leading surgeons and scientists who have researched and developed the use of Chondro-Gide® for cartilage regeneration in the knee, ankle, and hip.